IP Library Granted Patent US 7,297,483
Granted Patent B2
US 7,297,483 · App. 10/416,752 · Granted Nov 20, 2007

Isolated luciferases and the use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,297,483
App. No.
10/416,752
Granted
Nov 20, 2007
Kind
B2
Abstract

This invention relates to an isolated nucleic acid molecule which is a) a nucleic acid molecule comprising SEQ ID No. 3, or b) a nucleic acid molecule which exhibits at least 90% sequence identity to the nucleic acid molecule of SEQ ID No. 3, and the claimed nucleic acid molecule encodes luciferase. It also relates to an expression vector and to a transformed host cell.

Claims (6)

1. An isolated nucleic acid molecule selected from the group consisting of

(a) a nucleic acid molecule comprising SEQ ID NO: 3;

(b) a nucleic acid molecule which exhibits at least 90% sequence identity to the nucleic acid molecule of SEQ ID NO: 3, and wherein said nucleic acid molecule encodes luciferase.

2. The nucleic acid molecule of claim 1 , wherein the sequence contains a functional promoter located 5′ to the coding strand of the sequence.

3. An expression vector comprising the nucleic acid molecule according to claim 2 .

4. A transformed host cell comprising the vector of claim 3 .

Assignments (2)
CHANGE OF NAME Recorded Dec 21, 2016
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 041171/0788 →
MERGER Recorded Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →